JSE healthcare shares have risen, led by Aspen Pharmacare’s 40% gain; the result of ga R28bn business disposal, improved finances and manufacturing progress. Netcare gained 12% and Life Healthcare 6%, supported by operational efficiencies and cost reductions. However, analysts warn that sustained growth depends on Aspen’s execution and stronger hospital patient volumes, constrained by medical scheme affordability pressures. – Business Times (11 October 2026)